Search results
mRNA medicine contains no animal products or preservatives, making medicine accessible for as many people as possible. Our platform enables rapid design, research and testing of multiple mRNAs, within days. Our novel production methods allow us to get medicines to more people, faster.
- Moderna
Created by leading experts in the field, these programs will...
- Investor Relations Overview - Moderna
At Moderna, we promise to treat your data with respect and...
- Our Story - Moderna
Since 2010, we have worked to build the industry's leading...
- Moderna Achieves Positive Interim Results from Phase 3 Trial ...
The NEXTCove clinical trial is a randomized, observer-blind,...
- Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine
Moderna's updated COVID-19 vaccine contains spike proteins...
- Moderna Advances Multiple Vaccine Programs to Late-Stage ...
Moderna is advancing five vaccine candidates against viruses...
- Moderna
Since 2010, we have worked to build the industry's leading mRNA technology platform. Learn more about Moderna’s history.
Moderna, Inc. (/ m ə ˈ d ɜːr n ə / mə-DUR-nə) [4] is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.
Nov 1, 2023 · Information about Moderna COVID-19 Vaccine, Bivalent. Updated, bivalent mRNA COVID-19 vaccines are now FDA-authorized for all doses for individuals ages 6 months and older.
Mar 26, 2024 · The NEXTCove clinical trial is a randomized, observer-blind, active-controlled study of approximately 11,400 individuals aged 12 years and older in the United States, United Kingdom and Canada. mRNA-1283 was found to have a similar safety profile to Moderna's approved COVID-19 vaccines.
Sep 11, 2023 · Moderna's updated COVID-19 vaccine contains spike proteins for the XBB.1.5 sublineage of SARS-CoV-2 to help prevent COVID-19 in individuals 6 months of age and older. With the U.S. FDA's decision, Moderna will begin shipping doses to vaccination sites across the U.S., with updated vaccines expected to be available in the coming days.
Mar 27, 2024 · Moderna is advancing five vaccine candidates against viruses that cause latent infections, all of which are in clinical trials. When latent, a virus is present in the body but exists in a resting state, typically without causing any noticeable symptoms.
